Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Titan Pharmaceuticals Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +3 vs. Q3 2022
- Shares held
- 968.0K
- −86.4K (−8.2%) vs. Q3 2022
- Total value
- $757.9K
- −$378.1K (−33.3%) vs. Q3 2022
- New holders
- 6
- 4 more added
- Sold out
- 3
- 6 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TTNP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $69 |
| Q1 2026 | 6 | $130 |
| Q4 2025 | 4 | $154 |
| Q3 2025 | 18 | $107.1K |
| Q2 2025 | 20 | $158.3K |
| Q1 2025 | 17 | $51.9K |
| Q4 2024 | 15 | $9.41K |
| Q3 2024 | 16 | $88.5K |
| Q2 2024 | 18 | $179.3K |
| Q1 2024 | 17 | $230.0K |
| Q4 2023 | 24 | $408.2K |
| Q3 2023 | 27 | $497.8K |
| Q2 2023 | 25 | $632.7K |
| Q1 2023 | 22 | $787.4K |
| Q4 2022 | 23 | $757.9K |
| Q3 2022 | 21 | $1.14M |
| Q2 2022 | 24 | $371.0K |
| Q1 2022 | 24 | $1.24M |
| Q4 2021 | 24 | $430.0K |
| Q3 2021 | 22 | $722.0K |
| Q2 2021 | 23 | $1.51M |
| Q1 2021 | 24 | $988.1K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Titan Pharmaceuticals Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truist Financial Corp | 625,089 | $489.5K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 134,410 | $105.0K | 0.00% | −10,300−7.1% | Reduced |
| Vanguard Group Inc | 82,051 | $64.3K | 0.00% | +127+0.2% | Added |
| Geode Capital Management, LLC | 63,965 | $50.0K | 0.00% | −127−0.2% | Reduced |
| State Street Corp | 38,287 | $30.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 20,080 | $16.0K | 0.00% | −8,251−29.1% | Reduced |
| Level Financial Advisors, Inc. | 987 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,612 | $1.00K | 0.00% | +1,612 | New |
| FMR LLC | 342 | $268 | 0.00% | +341+34,100.0% | Added |
| Group One Trading, L.P. | 303 | $237 | 0.00% | +303 | New |
| Bank of America Corp | 206 | $161 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 200 | $156 | 0.00% | +200 | New |
| UBS Group AG | 165 | $129 | 0.00% | −11,011−98.5% | Reduced |
| Wells Fargo & Company | 77 | $60 | 0.00% | +2+2.7% | Added |
| BlackRock Inc. | 60 | $47 | 0.00% | 00.0% | Unchanged |
| Global Wealth Strategies & Associates | 40 | $31 | 0.00% | +40 | New |
| Morgan Stanley | 28 | $22 | 0.00% | −12−30.0% | Reduced |
| Advisor Group Holdings, Inc. | 37 | $18 | 0.00% | +23+164.3% | Added |
| Newbridge Financial Services Group, Inc. | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 2 | $2 | 0.00% | +2 | New |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 61 | $0 | 0.00% | +61 | New |
| IFP Advisors, Inc | 14 | – | – | −830−98.3% | Reduced |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −28,025−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −17,467−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −13,076−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |